Clinical Trials Browser

Phase 2 × Precancerous Conditions × sintilimab × Clear all

NCT04065737 2019-08-22

STOP

Phase 2 Unknown

Head & NeckOther neoplasm

Mouth Neoplasms, Precancerous Conditions